RIA
AH

Regal Investment Advisors’s Accretive Health AH Stock Holding History

Regal Investment Advisors’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-89
Closed -$1K – 981
2013
Q2 		$1K Buy
+89
New +$936 ﹤0.01% 877

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Regal Investment Advisors's AH Position: Q3 2013 in Review

Regal Investment Advisors sold out of Accretive Health (AH) in Q3 2013, closing a stake of 89 shares — an estimated $1K sold.

Regal Investment Advisors first reported a position in AH in Q2 2013 and held it in 1 quarter. The position peaked at $1K in Q2 2013. 99 funds tracked by Wall St. Rank hold AH as of Q3 2013.

  • Regal Investment Advisors reported no remaining Accretive Health position as of Q3 2013 after selling out during the quarter.
  • Regal Investment Advisors sold 89 Accretive Health shares in Q3 2013, an estimated $1K.
  • Regal Investment Advisors first reported a position in Accretive Health in Q2 2013 and held it in 1 quarter.
  • Regal Investment Advisors's Accretive Health position peaked at $1K in Q2 2013.
  • 99 funds tracked by Wall St. Rank held Accretive Health as of Q3 2013.

Based on Regal Investment Advisors's 13F filing for Q3 2013, filed 12 Nov 2013.